Overview
Pinealon is a synthetic short-chain bioregulator composed of three amino acids (Glu-Asp-Arg). Developed at the St. Petersburg Institute of Bioregulation and Gerontology, it is designed to target the central nervous system and the pineal gland. Unlike many neuroprotective agents that only act on cell surfaces, Pinealon is capable of entering the cell nucleus to modulate gene expression, which helps repair damaged cellular structures and enhances the production of essential proteins for brain health.
The peptide is primarily valued for its ability to protect neurons from oxidative damage and environmental stressors like hypoxia. It has shown significant potential in improving memory, stabilizing circadian rhythms, and supporting the metabolic efficiency of mitochondria within the brain. Its multifaceted approach makes it a key tool for researchers looking into age-related cognitive decline, traumatic brain injury recovery, and general mental performance optimization.
Mechanism of action
A synthetic tripeptide that penetrates the cell nucleus to interact with DNA, regulating gene expression to reduce apoptosis and boost antioxidant defenses.
Reported benefits
- ▸Enhances memory retention and cognitive focus by supporting hippocampal function.
- ▸Provides robust neuroprotection against oxidative stress and free radical damage.
- ▸Assists in regulating sleep-wake cycles by supporting the pineal gland.
- ▸Promotes cellular longevity and DNA repair through gene expression modulation.
- ▸Accelerates recovery from brain-related fatigue or trauma.
Reported side effects
- ·None reported in current research literature
Often stacked with
EpitalonSemaxCerebrolysin